These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates. Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122 [TBL] [Abstract][Full Text] [Related]
23. Metal allergy and the surgical patient. Mayor MB; Merritt K; Brown SA Am J Surg; 1980 Apr; 139(4):477-9. PubMed ID: 6989280 [TBL] [Abstract][Full Text] [Related]
24. Serum leukocyte migration inhibitory activity and phytohemagglutinin stimulation of peripheral blood lymphocytes in paraproteinemia. A preliminary report. Petrini M; Ambrogi F; Polidori R; Azzarà A; Grassi B Boll Ist Sieroter Milan; 1981; 60(6):513-9. PubMed ID: 7046768 [No Abstract] [Full Text] [Related]
25. Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomas. Cavallo GP; Beatrice F; Poggio E; Bussi M; Di Fortunato V; Rendine S; Sartoris A; Cortesina G Boll Ist Sieroter Milan; 1980 May; 59(2):147-54. PubMed ID: 7006629 [TBL] [Abstract][Full Text] [Related]
26. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients. Crivii SM; Crişan M; Crişan M Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694 [TBL] [Abstract][Full Text] [Related]
28. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects. Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105 [TBL] [Abstract][Full Text] [Related]
29. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions. Pettersson T; Welin MG; Weber TH J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387 [TBL] [Abstract][Full Text] [Related]
30. [Isolation and testing of factors affecting macrophage and leukocyte migration]. Gankovskaia LV; Gvozdeva NA; Moskvina SN Lab Delo; 1986; (10):612-4. PubMed ID: 2432322 [No Abstract] [Full Text] [Related]
31. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF). Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762 [TBL] [Abstract][Full Text] [Related]
32. Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF). McCoy JL; Braatz JA; Ames RS; Herberman RB J Immunol; 1980 Jun; 124(6):2786-93. PubMed ID: 6989906 [No Abstract] [Full Text] [Related]
33. Correlation between membrane glycoprotein and detergent dissected membrane protein in the assessment of LMIF: a report of 51 ALA cases. Nayeem MA; Habibullah CM Indian J Pathol Microbiol; 1993 Jul; 36(3):260-4. PubMed ID: 8300172 [TBL] [Abstract][Full Text] [Related]
34. Certain characteristics of human lymphocyte migration inhibitory factors (LyMIF) and the effect of ampicillin on their appearance in unstimulated and PHA-stimulated cultures. Skopińska-Rózewska E; Madaliński W; Lukasik R Acta Physiol Pol; 1983; 34(3):353-67. PubMed ID: 6372368 [TBL] [Abstract][Full Text] [Related]
35. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). Cruikshank W; Center DM J Immunol; 1982 Jun; 128(6):2569-74. PubMed ID: 7042841 [No Abstract] [Full Text] [Related]
36. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients]. Puppo F; Corsini G; Mangini P; Armani U; Piana A Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916 [No Abstract] [Full Text] [Related]
37. Effect of sera from cancer patients on human polymorphonuclear leukocyte random migration. Puppo F; Corsini G; Zavarise GM; Di Benedetto G Boll Ist Sieroter Milan; 1981; 60(6):520-5. PubMed ID: 7046769 [No Abstract] [Full Text] [Related]
38. In vitro approaches to the pathogenetic mechanisms of multiple sclerosis by leukocyte migration inhibition. Smeraldi E; Cazzullo CL; Zibetti A; Bottinelli S Dis Nerv Syst; 1974 Jul; 35(7):335-9. PubMed ID: 17894092 [No Abstract] [Full Text] [Related]
39. Leukocyte migration-inhibition responses of nonvaccinated and vaccinated heifers to experimental infection with Brucella abortus. Dorsey TA; Deyoe BL Am J Vet Res; 1982 Mar; 43(3):548-50. PubMed ID: 6803624 [TBL] [Abstract][Full Text] [Related]
40. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood. Skopińska E; Lukasik R Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]